Clinical Trial Update: An IIT Clinical Study to Evaluate the Safety and Efficacy of a Single Intrathecal Injection of RJK002 in Patients With ALS [EARLY_Phase 1]

View source ↗

Summary

The document describes an investigator-initiated Phase 1 study to assess the safety and efficacy of a single intrathecal injection of RJK002 in ALS patients. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• RJK002

Snippet

Sponsor: RJK Biopharma Ltd | Conditions: Amyotrophic Lateral Sclerosis | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING